Press Releases
Non-Insulin Peptide Drugs Market Valuation, ROI Potential & Long-Term Growth Prospects 2026–2036
The global non-insulin peptide drugs market is on the cusp of transformative growth, valued at USD 61.5 billion in 2025 and projected to expand to USD 184.2
FMI
February 4, 2026